Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
Clinical trial NCT00687323 · COMPLETED
Trial details
- NCT number
- NCT00687323
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-30
- Primary completion
- 2011-05-09
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.